Lower-dose radiotherapy effective, safe for HPV+ head and neck cancer after induction chemo

Results of the phase II OPTIMA clinical trial indicate that patients with head and neck cancers associated with the human papilloma-virus, including those with advanced nodal disease, can receive substantially lower radiotherapy doses safely and effectively if they respond to induction chemotherapy initially.
Medical Xpress

Leave a Reply

  • (will not be published)

XHTML: You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>